Your browser doesn't support javascript.
loading
Production of Neutralizing Antibody.
Takemasa, Erika; Liu, Shuang.
Afiliação
  • Takemasa E; Department of Pharmacology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
  • Liu S; Department of Pharmacology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. liussmzk@m.ehime-u.ac.jp.
Methods Mol Biol ; 2766: 93-106, 2024.
Article em En | MEDLINE | ID: mdl-38270870
ABSTRACT
Techniques employing monoclonal antibodies (mAbs) are widely used in the initial development phase of biologics. The usefulness of mAbs in basic RA research has been established based on their characteristics, including specificity of binding, homogeneity, and ability to be produced on a large scale. MAb immunoglobulins are the starting material for the generation of smaller antibody fragments and other engineered immunomodulatory antibodies. In this chapter, the basic hybridoma technique, which is a well-established and feasible method for the production of mAbs involving animal immunization, cell fusion, hybridoma screening, expanding positive hybridomas, and purification, is introduced. Aiming at specific affinity to a membrane protein, synthetic proteoliposomes are used in the immunization and screening steps.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Anticorpos Neutralizantes Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Anticorpos Neutralizantes Idioma: En Ano de publicação: 2024 Tipo de documento: Article